Toma Aurel, Gick Michael, Minners Jan, Ferenc Miroslaw, Valina Christian, Löffelhardt Nikolaus, Gebhard Catherine, Riede Florian, Neumann Franz-Josef, Buettner Heinz Joachim
Division of Cardiology and Angiology II, University Heart Center Freiburg, Bad Krozingen, Bad Krozingen Suedring 15, 79189, Bad Krozingen, Germany.
Clin Res Cardiol. 2016 Nov;105(11):921-929. doi: 10.1007/s00392-016-1000-2. Epub 2016 Jun 1.
There is limited data on prognosis after percutaneous coronary intervention (PCI) for coronary chronic total occlusions (CTO) in the era of drug-eluting stents (DES).
This study investigates the specific contribution of CTO recanalization to the survival benefit of complete revascularization.
Consecutive patients who underwent PCI of a CTO at our center between 01/2005 and 12/2013 were followed for a median of 2.6 years (interquartile range 1.1-3.1 years). All-cause mortality was compared between patients with successful and failed PCI of CTO without and with adjustment for pertinent co-variables by the Cox models.
The study comprised 2002 patients with attempted PCI of CTO (mean age 65.2 ± 11 years, 17 % female), 82 % had multivessel disease. The CTO PCI was successful in 1662 (83 %) patients with a DES rate of 94 %. All-cause mortality was significantly lower in patients with successful PCI of CTO compared to failed PCI of CTO (15.3 vs. 25.9 % at 4 years; P < 0.001). In the multivariable model, both successful CTO PCI and complete revascularization were strong independent predictors of reduced long-term mortality (adjusted hazard ratio (HR) 0.72; 95 % confidence interval (CI) 0.53-0.97; P = 0.03 and adjusted HR 0.59; 95 % CI 0.42-0.82; P = 0.002). Also within the subset of incomplete revascularization, successful PCI of CTO was associated with reduced mortality (adjusted HR: 0.67; 95 % CI: 0.50-0.92; P = 0.012).
Successful CTO recanalization is an independent predictor for improved long-term survival. Persistent CTO lesions are associated with significantly worse survival than persistent non-occlusive coronary lesions.
在药物洗脱支架(DES)时代,关于经皮冠状动脉介入治疗(PCI)治疗冠状动脉慢性完全闭塞(CTO)后的预后数据有限。
本研究调查CTO再通对完全血运重建生存获益的具体贡献。
对2005年1月至2013年12月期间在本中心接受CTO PCI的连续患者进行了中位2.6年(四分位间距1.1 - 3.1年)的随访。通过Cox模型比较CTO PCI成功与失败患者的全因死亡率,并对相关协变量进行调整。
该研究纳入了2002例尝试进行CTO PCI的患者(平均年龄65.2±11岁,17%为女性),82%患有多支血管病变。1662例(83%)患者的CTO PCI成功,DES使用率为94%。CTO PCI成功患者的全因死亡率显著低于CTO PCI失败患者(4年时分别为15.3%和25.9%;P<0.001)。在多变量模型中,成功的CTO PCI和完全血运重建都是降低长期死亡率的强有力独立预测因素(调整后风险比(HR)为0.72;95%置信区间(CI)为0.53 - 0.97;P = 0.03,调整后HR为0.59;95%CI为0.42 - 0.82;P = 0.002)。在不完全血运重建亚组中,成功的CTO PCI也与死亡率降低相关(调整后HR:0.67;95%CI:0.50 - 0.92;P = 0.012)。
成功的CTO再通是改善长期生存的独立预测因素。持续性CTO病变与持续性非闭塞性冠状动脉病变相比,生存率显著更差。